JAMA and Dartmouth on Mammograms <50

Gooz News summarizes an article on the USPSTF recommendation on mammography from the evidence-based medicine group at Dartmouth.  It is part of a group of  commentaries on the topic in the Journal of the American Medical Association -- you need subscription or access via a library. Without screening, 3.5 of 1000 women in their 40s … Continue reading JAMA and Dartmouth on Mammograms <50

Advertisement

Obit: Rita Arditti, health and human rights activist

Update 1/26 Barbara Brenner of Breast Cancer action on Arditti. Boston Globe Obit. BHN learned of the late Rita Arditti a few years back at a meeting of the Women's Community Cancer Project, a group that takes a feminist approach to cancer activism. Her obit in The Cambridge Chronicle -- she died Christmas day -- … Continue reading Obit: Rita Arditti, health and human rights activist

Coakley take note: State requires coverage for outdated breast cancer treatment

BHN did a double take this morning on the Globe story about the Senate candidates' debate about mandated insurance coverage. Apparently, the state still requires insurers to cover the cost of bone marrow transplants for breast cancer, even though researchers concluded TEN years ago that the procedure doesn't work. (WBUR had the story as well.) … Continue reading Coakley take note: State requires coverage for outdated breast cancer treatment

Goodman on mammography: Policyspeak v. pink ribbons

Globe-based national columnist Ellen Goodman writes today about how badly the USPSTF delivered the message on the limits of mammography in women under 50. She agrees with their recommendations. She just thinks the panel was blindsided by extremely angry women who are not willing to reconsider the notion that early detection is key to cancer survival.  Then there was the anti-health … Continue reading Goodman on mammography: Policyspeak v. pink ribbons

Health Wonk Review: Killer viruses and the undead public option

Killer viruses, computers that see all, and the undead public option. (Or, as Jon Stewart said last night --"It's alive!") Welcome to the haunted edition of the Health Wonk Review --  the  floating digest of posts from the health policy blogosphere. This week, we put the death back into death panels.  The health care system is an … Continue reading Health Wonk Review: Killer viruses and the undead public option

Screening for Cancer Questioned

BHN thinks this it is huge that the American Cancer Society finally admitted that cancer screening sometimes leads to overdiagnosis. Or did they? This blog item from the Associations of Health Care Journalists notes that ACS backpedaled a day after the NYTimes reported on the society's change of heart. Check out their links too.   (Times writer Gina) Kolata’s story … Continue reading Screening for Cancer Questioned

FDA doc takes heat for strict standards on new cancer drugs

 I had a long wait for the Red Line and a gratis NY Times from the BU Comm school. So, I read this piece about the FDA doc who is trying to protect patients from marginally useful cancer drugs. Dr. Richard Pazdur, director of the Food and Drug Administration’s cancer drug office "has helped to … Continue reading FDA doc takes heat for strict standards on new cancer drugs

Me, my mom, my kid and breast cancer + health reform reality checks

(I think technically that should say "My mom, my kid and I" but "me" sounds better here. ) Kaiser Health News has a good roundup of stories this morning on the response to the anti-health reform Teabaggers. The NY Times refers to a new WH web page called “Health Insurance Reform Reality Check.”  Also, will the La Leche … Continue reading Me, my mom, my kid and breast cancer + health reform reality checks

Priorities for Comparative Effectiveness + Senate and health reform

The Institute of Medicine, a Congressional research arm, released a list of  “100 health topics  (.pdf) that should get priority attention and funding from a new national research effort to identify which health care services work best.” Among the high priority issues: atrial fibrillation, hearing loss, fall prevention for the elderly, MRSA prevention, localized prostate cancer,  … Continue reading Priorities for Comparative Effectiveness + Senate and health reform

Patient group joins breast cancer gene patent suit

Many Boston orgs have reps working with this not-into-pink,  Bay-area group, including Silent Spring Institute, Our Bodies, Ourselves and local breast cancer activist groups.  Here from Breast Cancer Action’s press release:  Breast Cancer Action (BCA) is challenging the legality of patenting human “breast cancer genes.” BCA is joining the American Civil Liberties Union in suing Myriad … Continue reading Patient group joins breast cancer gene patent suit